March 27, 2017 / 12:50 PM / 8 months ago

BRIEF-PhaseRx reports Q4 loss per share of $0.30

March 27 (Reuters) - Phaserx Inc

* PhaseRx reports fourth quarter and full year 2016 financial results and provides corporate update

* Q4 loss per share $0.30

* As of December 31, 2016, company had cash, cash equivalents, and marketable securities of $15.5 million

* Believes it has sufficient cash to fund its operations for at least next 12 months

* In 2017, anticipate completing GLP toxicology and GMP manufacturing activities and submitting an ind for PRX-OTC in Q4 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below